HIV/AIDS Topics Nationwide PrEP Search Engine Debuts at U.S. Conference on AIDS
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 16 September 2016 00:00
- Written by Emory University
Emory University and partners have developed a new web-based directory of PrEP providers across the U.S., launching the project at the U.S. Conference on AIDS taking place this week in Hollywood, Florida. The search engine can be used to help people find physicians or clinics in their area that will prescribe Truvada (tenofovir/emtricitabine) for HIV prevention.
AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable
- Details
- Category: HIV Prevention
- Published on Thursday, 08 September 2016 00:00
- Written by Roger Pebody
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer HIV infections, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use, and preferred it to possible alternatives such as tablets or vaginal gels.
AIDS 2016: Study Looks at Use of HIV PrEP Before and During Pregnancy and Breastfeeding
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 25 August 2016 00:00
- Written by Liz Highleyman
Truvada for pre-exposure prophylaxis (PrEP) when it was offered as an additional tool for preventing HIV infection during the pre-conception period, pregnancy, and breastfeeding, according to study findings presented at the 21st International AIDS Conference (AIDS 2016) last month in Durban and published in the July 19 online edition of the American Journal of Obstetrics and Gynecology.
AIDS 2016: PrEP Study Achieves High Engagement and Adherence Among Black Gay Men
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 02 September 2016 00:00
- Written by Gus Cairns
What was described at the 21st International AIDS Conference (AIDS 2016) as the first PrEP trial devised and run by black gay men has shown that high levels of pre-exposure prophylaxis (PrEP) use, retention, and adherence can be achieved in a demonstration project if recruitment and support structures are tailored to the needs of black men who have sex with men.
Truvada PrEP for HIV Prevention Approved in European Union
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 24 August 2016 00:00
- Written by HIVandHepatitis.com
The European Commission, which has authority over new drug in the European Union, has approved Truvada (tenofovir/emtricitabine) for HIV pre-exposure prophylaxis or PrEP, Gilead Sciences announced this week. While this marketing authorization allows Truvada for PrEP to be sold throughout the EU, regulatory authorities in each country have the final say over whether to approve it and national health systems will decide whether to offer PrEP widely and pay for it.
More Articles...
- Most Contraceptives Not Linked to HIV Infection, but Depo-Provera May Raise Risk
- AIDS 2016: Vaginal Bacteria May Increase HIV Susceptibility and Reduce PrEP Effectiveness
- AIDS 2016: No New HIV Infections Seen in San Francisco's Strut PrEP Program
- Coverage of 21st International AIDS Conference (AIDS 2016)
Web Design and Development by